Tip 1 Diyabet Hastalar\u0131 \u0130\u00e7in Yeni Umut<\/p>\n
Britanya’dan 36 ya\u015f\u0131ndaki Hannah Robinson, Tip 1 diyabetle ya\u015fayan ilk yeti\u015fkinlerden biri olarak, Teplizumab adl\u0131 yeni bir deneysel ila\u00e7 tedavisinden ge\u00e7ti.<\/p>\n
\u015eii Haber Ajans\u0131’n\u0131n Dijitato’dan aktard\u0131\u011f\u0131 habere g\u00f6re, bu ila\u00e7 v\u00fccudun ba\u011f\u0131\u015f\u0131kl\u0131k sistemini yeniden e\u011fitmek amac\u0131yla tasarlanm\u0131\u015ft\u0131r ve s\u00fcrekli ins\u00fclin enjeksiyonlar\u0131n\u0131n aksine do\u011fal ins\u00fclin \u00fcretimini koruyabilir.<\/p>\n
Teplizumab\u2019\u0131n erken a\u015famalarda kullan\u0131lmas\u0131, ins\u00fclin enjeksiyonu ihtiyac\u0131n\u0131n ba\u015flamas\u0131n\u0131 \u00fc\u00e7 y\u0131l kadar geciktirebilir.<\/p>\n
Tip 1 diyabet, ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin v\u00fccudun pankreastaki ins\u00fclin \u00fcreten h\u00fccrelerine sald\u0131rd\u0131\u011f\u0131 bir otoimm\u00fcn hastal\u0131kt\u0131r.<\/p>\n
Doktorlar, bu yeni tedavinin Tip 1 diyabetin tedavisi ve kontrol\u00fc s\u00fcrecinde \u00f6nemli bir d\u00f6n\u00fc\u015f\u00fcm sa\u011flamas\u0131n\u0131 umut ediyor.<\/p>\n
\u0130lac\u0131n Amerika Birle\u015fik Devletleri’ndeki ilk denemeleri \u00fcmit verici sonu\u00e7lar vermi\u015f olup, \u015fu anda Britanya’da deney a\u015famas\u0131na ge\u00e7ilmi\u015ftir.<\/p>\n
Teplizumab, hastal\u0131\u011f\u0131n ancak ilk te\u015fhis a\u015famalar\u0131nda kullan\u0131ld\u0131\u011f\u0131 takdirde etkili olacakt\u0131r.<\/p>\n
Doktorlar ayr\u0131ca, ilac\u0131n hafif yan etkilere sahip oldu\u011funu ve hastalar\u0131n ya\u015fam kalitesini art\u0131rd\u0131\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131lar.<\/p>\n","protected":false},"excerpt":{"rendered":"
Tip 1 Diyabet Hastalar\u0131 \u0130\u00e7in Yeni Umut Britanya’dan 36 ya\u015f\u0131ndaki Hannah Robinson, Tip 1 diyabetle ya\u015fayan ilk yeti\u015fkinlerden biri olarak, Teplizumab adl\u0131 yeni bir deneysel ila\u00e7 tedavisinden ge\u00e7ti. \u015eii Haber Ajans\u0131’n\u0131n Dijitato’dan aktard\u0131\u011f\u0131 habere g\u00f6re, bu ila\u00e7 v\u00fccudun ba\u011f\u0131\u015f\u0131kl\u0131k sistemini yeniden e\u011fitmek amac\u0131yla tasarlanm\u0131\u015ft\u0131r ve s\u00fcrekli ins\u00fclin enjeksiyonlar\u0131n\u0131n aksine do\u011fal ins\u00fclin \u00fcretimini koruyabilir. Teplizumab\u2019\u0131n erken …<\/p>\n","protected":false},"author":1,"featured_media":116285,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[3185],"tags":[],"class_list":["post-116286","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_wp_page_template":null,"_wp_attached_file":null,"_wp_attachment_metadata":null,"_edit_lock":null,"yoast_head":"\n